Our chairman and Co-founder Dr. Latha Poonamallee sat down for an interview with BioSpectrum Asia March edition.
Dr Latha gave an idea about our company and our product, NeuroShield. It is a first of its kind product to use georgraphy and population based reference and test subjects.
We are also aiming for FDA approval and CE marking and we would be finishing it by the end of 2020. As quoted by Dr. Latha; “This is an exciting time for us. We are planning to
expand our product portfolio.”